Philip J. Vickers's most recent trade in Akebia Therapeutics Inc. was a trade of 214,400 Stock Option (Right to buy) done . Disclosure was reported to the exchange on April 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Akebia Therapeutics Inc | Philip J. Vickers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2026 | 214,400 | 214,400 | - | - | Stock Option (Right to buy) | |
| Tectonic Therapeutic Inc | Philip J. Vickers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 17,643 | 17,643 | - | - | Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Philip J. Vickers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,478 | 17,478 | - | - | Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Philip J. Vickers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,478 | 17,478 | - | - | Stock Option (Right to Buy) | |
| Revance Therapeutics Inc | Philip J. Vickers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2022 | 10,756 | 10,756 | - | - | Stock Option (Right to buy) |